When Tracy Dunbrook, a bioethicist in Sherman, Conn., tested positive for the BRCA gene mutation, she was told she had a 40 to 60 percent chance of developing ovarian cancer in her lifetime. Doctors advised her to have her ovaries removed.
Women with BRCA mutations often opt for risk-reducing salpingo-oophorectomy (RRSO). But there is a debate among experts over whether this strategy is the best one for all women, and many patients are caught in the middle, struggling to balance conflicting information about hysterectomy as part of risk-reducing surgery.
Share this article
Read the full, original story here: Weighing Surgeries in Light of a Breast Cancer Gene
